Cure enters this GSL Season 2 Group Stage BO3 as the clear frontrunner in trader pricing, driven by his strong 2026 form across Code S rounds and consistent results in TvP matchups. The South Korean Terran has posted multiple series wins in recent weeks, including advancement through Ro8 groups against high-level opposition, while leveraging disciplined macro play and map-specific adaptations on the current pool. In contrast, Protoss veteran sOs has posted a string of early exits and straight-set losses, including to ByuN in the same group stage, reflecting inconsistent execution and vulnerability to aggressive Terran timings. Head-to-head trends and recent patch stability further tilt implied probabilities toward Cure, though sOs retains upset potential through creative all-ins or proxy strategies in shorter series.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · UpdatedCure vs sOs
Moneyline
$110 Vol.
Map 1 Winner
$816 Vol.
Map Handicap
$100 Vol.
Total Games
$100 Vol.
This market will resolve to "Cure" if Cure win the match against sOs.
This market will resolve to "sOs" if sOs win the match against Cure.
If the match is canceled (not played at all), ends in a tie, or is delayed beyond 7 days from the scheduled date without a winner determined, this market will resolve to 50-50.
If the match begins but is not completed, and one team wins due to the opponent's forfeiture, disqualification, or walkover, this market will resolve to the team who wins.
If the match ends in a forfeit, disqualification, or walkover (team withdraws before the start and the other wins automatically), this market will resolve to 50-50.
The resolution source for this market will be official information from https://liquipedia.net/starcraft2/Main_Page. However, if https://liquipedia.net/starcraft2/Main_Page has not published final results within 2 hours after the event’s conclusion, a consensus of credible reporting may be used instead including video evidence.
In cases where a team’s listed name includes minor discrepancies from the resolution source, this market will resolve based on the underlying real-world match rather than exact name matching. Recognizable abbreviations, alternate or erroneous spellings, sponsor tags, affiliate or academy designations, regional identifiers, and minor formatting differences will be treated as referring to the same team, provided the intended team can be clearly and uniquely identified within the relevant competition. If a listed team name has no reasonable connection to any participating team, or if it matches or could reasonably refer to another team in the same competition such that the intended team cannot be unambiguously determined, this market will resolve 50-50.
Market Opened: May 19, 2026, 6:00 PM ET
Resolution Source
https://liquipedia.net/starcraft2/Main_PageResolver
0x65070BE91...Cure vs sOs
Moneyline
$110 Vol.
Map 1 Winner
$816 Vol.
Map Handicap
$100 Vol.
Total Games
$100 Vol.
This market will resolve to "Cure" if Cure win the match against sOs.
This market will resolve to "sOs" if sOs win the match against Cure.
If the match is canceled (not played at all), ends in a tie, or is delayed beyond 7 days from the scheduled date without a winner determined, this market will resolve to 50-50.
If the match begins but is not completed, and one team wins due to the opponent's forfeiture, disqualification, or walkover, this market will resolve to the team who wins.
If the match ends in a forfeit, disqualification, or walkover (team withdraws before the start and the other wins automatically), this market will resolve to 50-50.
The resolution source for this market will be official information from https://liquipedia.net/starcraft2/Main_Page. However, if https://liquipedia.net/starcraft2/Main_Page has not published final results within 2 hours after the event’s conclusion, a consensus of credible reporting may be used instead including video evidence.
In cases where a team’s listed name includes minor discrepancies from the resolution source, this market will resolve based on the underlying real-world match rather than exact name matching. Recognizable abbreviations, alternate or erroneous spellings, sponsor tags, affiliate or academy designations, regional identifiers, and minor formatting differences will be treated as referring to the same team, provided the intended team can be clearly and uniquely identified within the relevant competition. If a listed team name has no reasonable connection to any participating team, or if it matches or could reasonably refer to another team in the same competition such that the intended team cannot be unambiguously determined, this market will resolve 50-50.
Market Opened: May 19, 2026, 6:00 PM ET
Resolution Source
https://liquipedia.net/starcraft2/Main_PageResolver
0x65070BE91...Cure enters this GSL Season 2 Group Stage BO3 as the clear frontrunner in trader pricing, driven by his strong 2026 form across Code S rounds and consistent results in TvP matchups. The South Korean Terran has posted multiple series wins in recent weeks, including advancement through Ro8 groups against high-level opposition, while leveraging disciplined macro play and map-specific adaptations on the current pool. In contrast, Protoss veteran sOs has posted a string of early exits and straight-set losses, including to ByuN in the same group stage, reflecting inconsistent execution and vulnerability to aggressive Terran timings. Head-to-head trends and recent patch stability further tilt implied probabilities toward Cure, though sOs retains upset potential through creative all-ins or proxy strategies in shorter series.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · UpdatedBeware of external links.
Beware of external links.


Beware of external links.
Beware of external links.
Frequently Asked Questions